Cathepsin D inhibitors

Folia Histochemica et Cytobiologica

Volumn 45, Issue 4, 2007, Pages 291-313

  Gacko, Marek ^a   Minarowska, Alina ^a   Karwowska, Alicja ^a   Minarowski, Łukasz ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Aspatyl endopeptidase; Cathepsin D; Inhibitors

Indexed keywords

2 (2 AMINO 1 CYCLOHEXYL 3,5 DIHYDROXYPENT 6 YL) 1,3 DITHIANE; 2 AMINO 1 CYCLOHEXYL 3,4 DIHYDROXY 6 METHYLHEPTANE; 2 AMINO 1 CYCLOHEXYL 3,5 DIHYDROXY 6 METHYLHEPTANE; 2 AMINO 1 CYCLOHEXYL 3,5 DIHYDROXYHEPTANE; 3,4 DICHLOROISOCOUMARIN; ALPHA 2 MACROGLOBULIN; ANTIPAIN; ASPARTIC ACID; CARBOXYPEPTIDASE C; CATHEPSIN B; CATHEPSIN D; CATHEPSIN D INHIBITOR; CATHEPSIN E; CHYMOSIN; CHYMOSTATIN; CYSTEINE PROTEINASE INHIBITOR; DEXTRO PHENYLALANYLPROLYL DEXTRO PHENYLALANYL DEXTRO PHENYLALANYLVALYL DEXTRO LEUCINE; DEXTRO PHENYLALANYLPROLYLPHENYLALANYLPHENYLALANYLVALINE; DEXTRO PHENYLALANYLPROLYLPHENYLALANYLPHENYLALANYLVALYL DEXTRO LEUCINE; DITHIOTHREITOL; GASTRICSIN; GLUTAMYL DEXTRO PHENYLALANYLPROLYLPHENYLALANYLPHENYLALANYLVALYL DEXTRO LEUCINE; HYDROXYPEPSTATIN A; N [N (3 CARBOXYOXIRANE 2 CARBONYL)LEUCYL]AGMATINE; PEPSIN A; PEPSTANONE A; PEPSTATIN; PROTEINASE INHIBITOR; TETRANITROMETHANE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALZHEIMER DISEASE; ATHEROSCLEROSIS; BINDING AFFINITY; BURN; COMPETITIVE INHIBITION; CYTOTOXICITY; DRUG DISTRIBUTION; DRUG PROTEIN BINDING; DRUG SENSITIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME STRUCTURE; ENZYME SYNTHESIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HYPERTENSION; NONHUMAN; PROTEIN FUNCTION; REVIEW; STOMACH ULCER;

EID: 38849195522     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (226)

1. Davies DR. The sstructure and function of aspartic proteinases. Ann Rev Biophys Chem. 1990;19:189-215.
2. Ersmark K, Fejerberg I, Bjelie S, Hamelink E, Hackett F, Blackman MJ, Hulten J, Samuelsson B, Aqvist J, Hallberg A. Potent inhibitors of the Plasmoolium falciparum enzymes plasmepsin I and II deroid of cathepsin D inhibitory activity. J Med Chem. 2004;47:110-122.
3. Hill J, Phylip LH. Bacterial aspartic proteinases. FEBS Lett. 1997;409:357-360.
4. Ruchel R, DeBernardis F, Ray TL, Sullivan PA, Cole GT. Candida acid proteinase. J Med Vet Mycol. 1992;30:123-132.
5. Rupova L, Keilova H. Isolation and some properties of an acid protease from Fasciola hepatica. Z Parasitenkol. 1979;61:83-91.
6. Faust PL, Kornfeld S, Chirgwin JM. Cloning and sequence analysis of cDNA for human cathepsin D. Proc Natl Acad Sci USA. 1985;82:4910-4914.
7. Hasilik A. The early and late processing of lysosomal enzymes: proteolysis and compartmentation. Experientia. 1992;48:130-151.
8. Erickson AH, Conner GE, Blobel G. Biosynthesis of a lysosomal enzyme. Partial structure of two transient and functionally distinct NH2-terminal sequences in cathepsin D. J Biol Chem. 1981;256:11224-11231.
9. Larsen LB, Boisen A, Petersen TE. Procathepsin D cannot antoactivation to cathepsin D at acid pH. FEBS Lett. 1993;319:54-58.
10. Richo GR, Conner GE. Structural requirements of procathepsin D activation and maturation. J Biol Chem. 1994;269:14806-14812.
11. Wittlin S, Rosel J, Hofman F, Stover DR. Mechanism and kinetics of procathepsin D activation. Eur J Biochem. 1999;265:384-393.
12. Yonezawa S, Takahashi T, Wang X, Wong RNS, Hartsuck JA, Tang J. Structure at the proteolytic processing region of cathepsin D. J Biol Chem. 1988;263:16504-16511.
13. Lah T, Turk V. Autolysis studies of cathepsin D. Hoppe-Seyler's. Z Physiol Chem. 1982;363:247-254.
14. Puizdar V, Turk V. Cathepsinogen D: characterization and activation to cathepsin D and inhibitory peptides. FEBS Lett. 1981;132:299-304.
15. Samarel AM, Ferguson AG, Decker RS, Lesch M. Effects of cysteine protease inhibitors on rabbit cathepsin D maturation. Am J Physiol. 1989;257:C1069-C1079.
16. Authier F, Mort JS, Bell AW, Posner BL, Bergeron JJM. Proteolysin of glucagons within hepatic endosomes by membrane-associated cathepsin B and D. J Biol Chem. 1995;270:15798-15807.
17. Diment S, Leech MS, Stahl PD. Cathepsin D in membrane-associated in macrophage endosomes. J Biol Chem. 1988; 263:6901-6907.
18. Marciniszyn J, Hartsuck JA, Tang J. Mode of inhibition of acid proteases by pepstatin. J Biol Chem. 1976;251:7088-7094.
19. Van Noort JM, Van der Drift ACM. The selectivity of cathepsin D suggests an involvement of the enzyme in the generation of T-cell epitopes. J Biol Chem. 1989;264:14159-14164.
20. Ikeda K, Suzuki H, Okano T, Nakagawa S. Human spleen cathepsin D: its characterization and localization in human spllen. Int J Biochem. 1989;21:317-326.
21. Saftig P, Hetman M, Schmal W, Weber K, Heine L, Mossmann H, Koster A, Hess B, Evers M, von Figura K, Peters C. Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells. EMBO J. 1995;14:3599-3608.
22. Pagano M, Capony F, Rochefort H. In vitro activation of procathepsin B by cathepsin D both secreted by cancers cells. C R Acod Sci Paris, 1989;309:7-12.
23. Van der Stappen JWJ, Williams AC, Maciewicz RA. Activation of cathepsin B, secreted by a colorectal cancer cell line requires low pH and is mediated by cathepsin D. Int J Canc. 1996;67:547-554.
24. Wiederanders B, Kirschke H. The processing a cathepsin L precursor in vitro. Arch Biochem Biophys. 1989;272:516-521.
25. Morris BJ. Activation of human inactive ("pro") rennin by cathepsin D and pepsin. J Clin Endocrinol Metab. 1978;46:153-157.
26. Lenarcic B, Kos J, Dolenc I, Lucovnik P, Krizaj I, Turk V. Cathepsin D inactivates cysteine proteinase inhibitors cystatins. Biochem Biophys Res Commun. 1988;154:765-722.
27. Lenarcic B, Krasovec M, Ritonja A, Olafsson I, Turk V. Inactivation of human cystatin C and kininogen by human cathepsin D. FEBS Lett. 1991;280:211-215.
28. Kopitar M, Brzin J, Drobnic-Kosorek M, Babnik J, Locnikar P, Turk V, Giraldi T, Sava G. Some further characteristics of endogenous proteinase inhibitors. Acta Biol Med Germ. 1982;41:75-82.
29. Drobnic-Kosorok M, Kopitar M, Babnik J, Turk V. Inactivation studies of the leucocyte inhibitor of urakinase by cathepsin D. Mol Cell Biochem. 1981;36:129-134.
30. Sandhaus RA, Janoff A. Degradation of human α1-antytripsin by hepatocyte acid cathepsins. Ann Rev Resp Dis. 1974;110:263-272.
31. Pimenta DC, Chen VC, Chao J, Juliano MA, JulianoL. α1-antychymotrypsin and kallistatin hydrolysis by human cathepsin D. J Protein Chem. 200;19:411-418.
32. Conover CA, Perry JE, Tindall DJ. Endogenous cathepsin D-mediated hydrolysis of insulin-like growth factor-binding proteins in cultured human prostatic carcinoma cells. J clin Endocrinol Metab. 1995;80:987-992.
33. Diment S, Martin KJ, Stahl PD. Cleavage of parathyroid hormone in macrophage endosomes illustrates a novel pathway for intracellular processin of proteins. J Biol Chem. 1989;264:13403-13406.
34. Hilfiker-Kleiner D, Kamiński K, Podewski E, Bonda T, Schaefer A. A cathepsin D-clewved 16 kDa from of prolactin mediater postpartum cardiomyopathy. Cell. 2007;128:589-600.
35. Hook VYH, Azaryan AV, Hwang SR, Tezapsidis N. Proteases and emerging role of protease inhibitors in prohoruone processing. FASEB J. 1994;8:1269-1278.
36. Kageyama T. Rabbit procathepsin E and cathepsin E. Eur J Biochem. 1993;216:717-728.
37. Offermann MK, Chlebowski JF, Bond JS. Action of cathepsin D on fructose-1,6-bisphosphate aldolase. Biochem J. 1983;211:529-534.
38. Beaujouin M, Baghdiguian S, Glondu-Lassis M, Berchem G, Liaudet-Coopman E. Overexpression of both catalytically active and inactive cathepsin D by cancer cells enhances apoptosis-dependent chemo-sensivity. Oncogene. 2006;23:1967-1973.
39. Berchem G, Glondu M, Gleizes M, Brouillet JP, Vignon F, Garcia M, Liaudet-Coopman E. Cathepsin-D affects multiple tumor progression in vivo: proliferation, angiogenesis and apoptosis. Oncogene. 2002;21:5951-5955.
40. Chwieralski CE, Welte T, Buhling F. Cathepsin-regulated apoptosis. Apoptosis. 2006;11:143-150.
41. Davidson Y, Gibbons L, Pritchard A. Genetic associations Between cathepsin D exon 2 C→T polymorphism and Alzheimer's disease, and pathological correlations with genotype. J Neurol Neurosurg Psychiat. 2006;77:515-517.
42. Fusek M, Vetvicka V. Dual role of cathepsin D: ligand and protease. Biomed Papers. 2005;149:43-50.
43. Isidoro C. et al. Synthesis, maturation and extracellular release of procathepsin D as influenced by cell proliferation or transformation. Int J Canc. 1995;63:866-871.
44. Jedinak A, Maliar T. Inhibitors of proteases as anticancer drugs. Neoplasma. 2005;52:185-192.
45. Johanson AC, Steen H, Ollinger K, Roberg K. Cathepsin D mediates cytochrome C release and caspase activation in human fibroblast apoptosis induced by staurosporine. Cell Deafh Different. 2003;10:1253-l259.
46. Laurent-Matha V, Maruani-Herrman S, Prebois C, Beaujoin M, Gondu M. Catalytically inactive human cathepsin D triggers fibroblast invasive growth. J Cell Biol. 2005;168:489-499.
47. Leist M, Jäättelä M. Triggering of apoptosis by cathepsins. Cell Death Different. 2001;8:324-326.
48. Liaudet-Coopman E, Beaujonin M, Derocq D, Garcia M, Glondu-Lassis M, Laurent-Matha V, Prebois C, Rochefort H, Vigon F. Cathepsin D: newly discovered functions of a long-standing aspartic protease in cancer and apoptosis. Cancer Lett. 2006;237:167-179.
49. Minarowska A, Minarowski L, Karwowska A, Gacko M. Regulatory role of cathepsin D in apoptosis. Folia Histochem Cytobiol. 2007;45:159-163.
50. Roberg K, Ollinger K. Oxidative stress causes relacation of the lysosomal enzyme cathepsin D with ensuing apoptosis in neonatal rat cardiomyocytes. Am J Pathol. 1998;152:1151-1156.
51. Rochefort H, Liaudet E, Garcia M. Alternations and role of human cathepsin D in cancer metastasis. Enzyme Protein. 1996;49:106-116.
52. Simon DI, Ezratty AM, Loscalzo J. The fibrin(ogen)olytic properties of cathepsin D. Biochemistry. 1994;33:6555-6563.
53. Tian G, Solotka-Briners CD, Zysk J, Liu X, Birr C, Sylvester MA, Edwards PD, Scott CD, Greenberg BD. Linear non-competifive inhibition of solubilized human X-secretase by Pepstatin A methylester L685458, sulfonamides, and benzodiazepines. J Biol Chem. 2002;277:31499-31505.
54. Devasagayam TPA, Pushpendran CK, Eapen J. Cycloheximide-induced inhibition of cathepsin D activity in suckling and adult rats. Biochem Int. 1981;3:55-60.
55. Gordon PB, Seglen PO. Exogenous control of intracellular protein catabolism. In: Proteolytic enzymes a practical approach. Beynon RJ, Bond JS (eds). IRL Press Oxford. 1994:201-210.
56. Turk V, Lah T, Puizdar V, Kregar I, Pain RH. The existence of a precursor of cathepsin D: evidence from autolysis, denaturation and activation studies. Acta Biol Med Germ. 1981;40:1439-1450.
57. Dionyssiou-Asteriou A, Rakitzis ET. Activarion of cathepsin D by glycine ethl ester. Biochem J. 1979;177:355-356.
58. Watabe S, Ikeda T, Yago N. Activation of cathepsin D by polyanionic compounds. Bioch Molec Biol Int. 1996;39:703-710.
59. Watabe S, Yago N. Phospholipids activate cathepsin D. Biochem Biophys Res Commun. 1983;110:934-939.
60. Press EM, Porter RR, Cebra J. The isolation and properties of a proteolytic enzyme cathepsin D from bovine spleen. Biochem J. 1960;74:501-514.
61. Kazakova OV, Orekhovich VN. Some properties of cathepsin chemically fixed to carriers. Int J Pept Prot Res. 1975;7:23-29.
62. Kimura H, Tsudzuki T, Murachi T. Proteolytic degradation of hemoglobin-haptoglobin compleks by lysosomal enzymes from rat liver. J Biochem. 1975;77:909-912.
63. Antonov VK. Chemistry of proteolysis. Springer-Verlag Berlin. 1993;246-276.
64. Bieth JG. Theoretical and practical aspects of proteinase inhibitors kinetics. Meth Enzymol. 1995;248:59-84.
65. Davidson VL, Sittman DB. Biochemistry. Harwal Publ Philadelphia. 1994:90-91.
66. Dixon M. The determination of enzyme inhibitor constans. Biochem J. 1953;55:170-171.
67. Worowski K. Cell proteolysis and its regulation. Post Biol Kom. 1977;4:243-278.
68. Ikezawa H, Aoyagi T, Takeuchi T, Umezawa H. Effect of protease inhibitors of actinomycetes on lysosomal peptide-hydrolases from swine liver. J Antibiot. 1971;14:488-490.
69. Barrett AJ. Cathepsin D and other carboxyl proteinases. In: Proteinases in mammalian cells and tissues. Barrett AJ (ed). North-Holland Amsterdam. 1977:209-248.
70. Fusek M, Mares M, Vagner J, Voburka Z, Baudys M. Inhibition of aspartic proteinases by propart peptides of human procathepsin D and chicken pepsinogen. FEBS Lett. 1991;287:160-162.
71. Masa M, Maresova L, Vondrasek J, Horn M, Jezek J, Mares M. Cathepsin D propeptide: mechanism and regulation of its interaction with the catalytic core. Biochemistry. 2006;45:15474-15482.
72. Starkey PM, Barrett AJ. α2-macroglobulin, a physiological regulator of proteinase activity. In: Proteinases in mammalian cells and tissue. Barrett AJ (ed). North-Holland Publ Comp Amsterdam. 1977:663-696.
73. Shibata M, Koike M, Waguri S, Zhang G, Koga T, Uchiyama Y. Cathepsin D is specifically inhibited by deoxyribonucleic acids. FEBS Lett. 2002;517:281-284.
74. Richardson M. The proteinase inhibitors of plants and microorganisms. Phytochemistry. 1977;16:159-169.
75. Takahashi K, Chang WJ, Ko JS. Specific inhibition of acid proteases from brain, kidney skelet muscle, and insectiovorous plants by diazoacetyl-DL-norleucine methyl ester and by pepstatin. J Biochem. 1974;76:897-899.
76. Worowski K. Cell inhibitors of proteolytic enzymes. Post Biol Kom. 1976;3:51-74.
77. Xie D, Gulnik S, Collins L, Gustchina E, Suvorov L, Erickson JW. Dissection of the pH dependence of inhibitor binding energetics for an aspartic protease: direct measurement of the protonation states of the catalytic aspartic acid residues. Biochemistry. 1997;36:16166-l6172.
78. Smith GD, Murray MA, Nichols LW, Trikojus VM. Thyroid acid proteinase. Properties and inactivation by diazoacetyl-norleucine methyl ester. Biochim Biophys Acta. 1969;171:288-298.
79. Keilova H. Inhibition of cathepsin D by diazoacetylnor-leucine methyl ester. FEBS Lett. 1970;6:312-314.
80. Bayliss RS, Knowles JR, Wybrandt EB. An aspartic acid residue at the active site of pepsin. The isolation and sequence of the heptapeptide. Biochem J. 1969;113:377-386.
81. Stepanov VM, Orekhovich VN, Lobareva LS, Mzhelskaya TI. Action of the pepsin inhibitor on the bovine spleen cathepsin D. Biochemistry (USSR). 1969;34:170-171.
82. Kaehn KK, Morr M, Kula MR. Inhibition of the acid proteinase from Neurospora crassa by diazoacetyl-DL-norleucine methyl ester, 1,2-epoxy-3-(4-nitrophenoxy) propane and pepstatin. Z Physiol Chem. 1979;360:791-794.
83. Kregar I, Stanovnik B, Tisler M, Nisi C, Gubensek F, Turk V. Inactivation studies of cathepsin D with diazo compounds. Acta Biol Med Germ. 1977;36:1927-1930.
84. Takahashi K, Chang WJ. The structure and function of acid proteases. V. Comparative studies on the specific inhibition of acid proteases by diazoacetyl-DL-norleucine methyl ester, 1,2-epoxy-3-(p-nitrophenoxy) propane and pepstatin. J Biochem. 1976;80:497-506.
85. Tang J. Evolution in the structure and function of carboxyl proteases. Mol Cell Biochem. 1979;26:93-109.
86. Rao CM, Scarborough PE, Kay J, Batley B, Rapundalo S, Klutchko S, Taylor MD, Lunney EA, Humblet CC, Dunn BM. Specificity in the binding of inhibitors to the active site of human/primate aspartic proteinases: analysis of P2-P1-P1,-P2, wariations. J Med Chem. 1993;36:2614-2620.
87. Rakitzis ET, Malliopoulou TB. Inactivation of cathepsin D by dithiophosgene and by 2,2-dichloro-1,3-dithiacyclobutanone. Biochem J. 1976;153:737-739.
88. Keilova H, Markovic O, Keil B. Characterization and chemical modification of cathepsin D from bovine spleen. Collect Czech Chem Commun. 1969;34:2154.
89. Keilowa H, Keil B. Specificity of cleavage of heptapeptide substrate with bovine spleen cathepsin D. Collect Czech Chem Commun. 1968;33:131-140.
90. Tang J. Specific and irreversible inactivation of pepsin by substrate - like epoxides. J Biol Chem. 1971;246:4510-4517.
91. Keilova H. On the specificity and inhibition of cathepsin D and B. In: Tissue proteinases. Barrett AJ, Diugle JT. North-Holland Publ Co Amsterdam. 1971:45-67.
92. Lin TY, Williams HR. inhibition of cathepsin D by synthetic oligopeptides. J Biol Chem. 1979;254:11875-11883.
93. Ikezawa H, Yamada K, Aoyagi T, Takeuchi T, Umezawa H. Effect of antipain on lysosomal peptide hydrolases from swine liver. J Antibiot. 1972;25:738-740.
94. Aoyagi T, Morishima H, Nishizawa R, KunimotoS, Takeuchi T. Biological activity of pepstatins, pepstatone A and partial peptides on pepsin, cathepsin D and renin. J Antibiot. 1972;25:689-694.
95. Doi E, Shibata D, Matoba T, Yonezawa D. Characterization of pepstatin-sensitive acid protease in resting rice seeds. Agric Biol Chem. 1980;44:741-747.
96. Gunn JM, Owens RA, Liu WS, Glover GJ. Biological activity of aspartic proteinases inhibitors related to pepstatin. Acta Biol Med Germ. 1981;40:1547-1553.
97. Jupp RA, Dunn BM, Jacobs JW, Vlasuk G, Arcuri KE, Veber DF, Perlow DS, Payne LS, Boger J, Laszlo S, Chakravarty PK, Broekes J, Hangauer DG, Ondeyka D, Greenlee WJ, Kay J. The selectivity of statine-based inhibitors against various human aspartic proteinases. Biochem J. 1990;265:871-878.
98. Woessnr JF. Pepstatin inhibits the digestion of hemoglobin and protein-polisaccharide complex by cathepsin D. Biochem Biophys Res Commun. 1972;47:965-970.
99. Evin G, Sharples RA, Weidman A, Reinhard FBM, Carbone V, Culvenor JG, Holsinger RM, Sernee MF, Beyreuter K, Masters CL. Aspartyl protease inhibitor pepstatin binds to the presenilins of Alzheimers disease. Biochemistry. 2001;40:8359-8368.
100. Wingender W. Proteinase inhibitors of microbial origin. In: Proteinase inhibitors. Fritz H, Tschesche H, Greene LJ, Truscheit E (eds). Springer Verlag. 1974:548-559.
101. Umezawa H. Protease inhibitors produced by microorganisms. Acta Biol Med Germ. 1977;36:1899-1915.
102. Baldwin ET, Bhat TN, Gulnik S, Hosur MV, Soder I, Cachau RE, Collin J, Silva AM, Erickson JW. Crystal structures of native and inhibited forms of human cathepsin D: implications for lysosomal targeting and drug design. Proc Natl Acad Sci USA. 1993;90:6796-6800.
103. Cooper JB. Aspartic proteinases indisease: a structural perspective. Curr Drug Targets. 2002;3:155-173.
104. Rich D. Pepstatin - derived inhibitors of aspartic proteinases. A close look at an apparent transitionstate analog inhibitor. J Med Chem. 1985;28:263-273.
105. Majer P, Collins JR, Gulnik SV, Erickson JW. Structure-based subside specificity mapping of human ethepsin D using statine-based inhibitors. Protein Sci. 1997;6:1458-1466.
106. Hasilik A, Figura K, Conzelman E, Nehrkorn H, Sandhoff K. Lysosomal enzyme precursors in human fibroblasts. Activation of cathepsin D precursor in vitro and activity of beta-hexosaminidase A precursor toward ganglioside GM2. Eur J Biochem. 1982;125:317-321.
107. Agarwal NS, Rich DH. Inhibition of cathepsin D by substrate analognes containing statine and by analognes of pepstatin. J Med Chem. 1986;29:2519-2524.
108. Boger J, Lober NS, Ulm EH. Novel renin inhibitors containing the amino acid statine. Nature. 1983;303:81-84.
109. Sarubbi E, Seneci PE, Angelastro MR, Peet NP, Denarto M, Islam K. Peptide aldehydes as inhibitors of HIV protease. FEBS Lett. 1993;319:253-256.
110. Wood JM, Gulati N, Forgiarini P, Fuhver W, Hofbauer KG. Effects of a specific and long-acting rennin inhibitor in the marmoset. Hypertension. 1985;7:797-803.
111. Tone H, Matsushita Y, Yagi Y, Takamatsu A, Aoyagi T, Takeuchi T, Umezawa H. Purification and properties of pepstatin hydrolase from Bacillus sphaericus. J Antibiot. 1975;28:1012-1015.
112. Matsushita Y, Tone H, Hori S, Yagi Y, Takamatsa A, Horishima H, Aoyagi T, Tekeuchi T, Umezawa H. N-acylated derivatives of a peptide obtained by enzymatic degradation of pepstatins. J Antibiol. 1975;28:1016-1018.
113. Dumas J, Brittelli D, Chen J, Dixon B, Hatoum-Mokdad H. Synthesis and structure activity relationships of novel small molecule cathepsin D inhibitors. Bioorg Med Chem Lett. 1999;9:2531-2536.
114. Huo S, Wang J, Cieplak P, Kollman PA, Kuntz ID. Molecular dynamics and free energy analysis of cathepsin D-inhibitor interactions: insight into structure-based ligand design. J Med Chem. 2002;45:1412-1419.
115. Kick EK, Roe DC, Skillman AG, Liu G, Ewing TJ, Sun Y, Kuntz ID, Ellman JA. Structural-based design and combinatorial chemistry yield low molecular inhibitors of cathepsin D. Chem Biol. 1997;4:297-307.
116. Lee CE, Kick EK, Ellman JA. General solid-phase synthesis approach to prepare mechanism-based aspartyl protease inhibitor libraries. Identification of potent cathepsin D inhibitors. J Am Chem Soc. 1998;120:9735-9747.
117. Farley PC, Christeller JT, Sullivan ME, Sullivan PA, Laing WA. Analysis of the interaction between the aspartic peptidase inhibitor SQAPI and aspartic peptidases using surface plasmon resonance. J Mol Recognit. 2002;15:135-144.
118. Koiwa H, Bressan RA, Hasegawa PM. Regulation of protease inhibitors and plant defense. Trends Plant Sci. 1997;2:379-384.
119. Mutlu A, Gal S. plant aspartic proteinases: enzymes ou the way to a function. Physiol Plant. 1999;105:569-576.
120. Ryan CA. Protease inhibitors in plants: genes for improving defenses against insects and pathogens. Ann Rev Phytopathol. 1990;28:425-449.
121. Taylor BH, Young RJ, Scheuring CF. Induction of a protease inhibitor II-class gene by aucin in tomato roots. Plant Molecul Biol. 1993;23:1005-10l4.
122. Baudys M, Ghosh M, Harlos K, Meres M, Fusek M, Kostka V, Blake CC. Crystallization and preliminary crystallographic study of cathepsin D inhibitor from potatoes. J Mol Biol. 1991;218:21-22.
123. Hannapel DJ. Nucleotide and deduced amino acid sequence of the 22-kilodalton cathepsin D inhibitor protein of potato (Solanum tuberosum L.). Plant Physiol. 1993;101:703-704.
124. Herbers K, Prat S, Willmitzer L. Cloning and characterization of a cathepsin D inhibitor gene from Solanum tuberosum L. Plant Molec Biol. 1994;26:73-83.
125. Keilova H, Tomasek V. Isolation and some properties of cathepsin D inhibitor from potatoes. Collect Czech Chem Commun. 1975;41:489-497.
126. Keilova H, Tomasek V. Naturally occurring inhibitors of intracellular proteinases. Acta Biol Med Germ. 1977;36:1873-1881.
127. Maganja DB, Strukelj B, Pungercar J, Gubensek F, Turk V, Kregar I. Isolation and sequence analysis of the genomic DNA fragment encoding and aspartic proteinase inhibitor homologue from potato (Solanum tuberosum L.). Plant Mol Biol. 1992;20:311-313.
128. Mares M, Fusek M, Kostka V, Baudys M. Cathepsin D inhibitor from potato tubers (Solanum tuberosum L.). Adv Exp Med Biol. 1991;306:349-353.
129. Mares M, Meloun B, pavlik M, Kostka V, Baudys M. primary structure of cathepsin D inhibitor from potatoes and its structure relationship to soybean trypsin inhibitor family. FEBS Lett. 1989;251:94-98.
130. Ritonja A, Krizaj I, Mesko P, Kopitar M, Lucovnik P, Strukelj B, Pungeracar J, Buttle DJ, Barrett AJ, Turk V. The amino acid sequence of a novel inhibitor of cathepsin D from potato. FEBS Lett. 1990;267:13-15.
131. Strukelj B, Pungercar J, Ritonja A, Krizaj I, Gubensek F, Kregar I, Turk V. Nucleotide and deduced amino acid sequence of an aspartic proteinase inhibitor homologue from potato tubers (Solanum tuberosum L.). Nucleic Acids Res. 1990;18:4605.
132. Dash C, Kulkarni A, Dunn B, Rao M. Aspartic peptidase inhibitors: implications in drug development. Crit Rev Biochem Molec Biol. 2003;38:89-119.
133. Ishikawa A, Ohta S, Matsuoka K, Hattori T, Nakamura K. A family of potato genes that encode Kunitz - type proteinase inhibitors i structural comparisons and differential expression. Plant Cell Physiol. 1994;35:303-312.
134. Guevara MG, Daleo GR, Oliva CR. Purification and characterieation of an aspartic protease from potato leaves. Physiol Plantorum. 2001;112:321-326.
135. Christeller JT, Farley PS, Ramsay RJ, Sullivan PA, Laing WA. Purification, characterization and cloning of an aspartic proteinase inhibitor from squash phloem exudates. Eur J Riochem. 1998;254:160-167.
136. Mucha D. The recognition of plant derived inhibitors of cathepsin D. M.B.S. Thesis (Polish), Pharmaceutical Faculty, Medical University of Bialystok, 1997.
137. Galleschi L, Friggeri M, Repiccioli R, Come D. Aspartic proteinase inhibitor from wheat: some properties. In: Proceedings of Fourth Int. Workshop Seads: basic and applied aspects of seed biology. Corbineau F. Angers France. 1993:207-211.
138. Sarkkinen P, Kalkkinen N, Tilgmann C, Siuro J, Kervinen J, Mikola L. Aspartic proteinase from barlej grains is related to mammalian lysosomal cathepsin D. Planta. 1992;186:317-323.
139. Cleveland TE, Black LL. Partial purification of proteinase inhibitors from tomato pants infected with Phytophtora infestans. Phytopathology. 1983;73:664-670.
140. Lison P, Rodrigo I, Conejero V. A novel function for the cathepsin D inhibitor in tomato. Plant Physiol. 2006;142:1329-1339.
141. Werner R, Guitton MC, Muhlbach HP. Nucleotiole sequence of a cathepsin-D inhibitor protein from tomato. Plant Physiol. 1993;103:1473.
142. Balandin T, Van der Does C, Belles AJM, Bol JF, Linthorst HJM. Structure and induction pattern of a novel proteinase inhibitor class II gene of tobacco. Plant Mol Biol. 1995;27:1197-1204.
143. Cater SA, Lees WE, Hill J, Kay J, Phylip LH. Aspartic proteinase inhibitors from tomato and potato are more potent against yeast proteinase A than cathepsin D. Biochim Biophys Acta. 2002;596:76-82.
144. Hansen JD, Hannapel DJ. A wound-inducible potato proteinase inhibitor gene expressed in non-tuber-bearing species is not sucrose inducible. Plant Physiol. 1992;100:164-169.
145. Farmer EE, Johnson RR, Ryan CA. Regulation of expression of proteinase inhibitor genes by methyl jasmonate and jasmonic acid. Plant Physiol. 1992;98:995-1002.
146. Ishikawa A, Yoshihara T, Nakamura K. Jasmonate-inducible expression of a potato cathepsin D inhibitor - GUS gene fusion in tobacco cells. Plant Mol Biol. 1994;26:403-414.
147. Kreft S, Ravnikar M, Mesko P, Pungercar J, Umek A, Kregar I, Strukelj B. Jasmonic acid inducible aspartic proteinase inhibitors from potato. Phytochemistry. 1997;44:1001-1006.
148. Pena-Cortes H, Sanchez-SerranoJ, Mertena R, Willmitzer L, Part S. Abscisic acid is involved in the wound-induced expression of the proteinasese inhibitor II gene in potato and tomato. Proc Natl Acad Sci USA. 1989;86:9851-9855.
149. Strukelj B, Ravnikar M, Mesko P, Poljsak-Prijatelj M, Pungercar J, Kopitar G, Kregar I, Turk V. Molecular cloning and immunocytochemical localization of jasmonic acid inducible cathepsin D inhibitor from potato. Adv Exp Med Biol. 1995;362:293-298.
150. Doares SH, Narvaez-Vasques J, Conconi A, Ryan CA. Salicylic acid inhibits synthesis of proteinase inhibitors in tomato leaves induced by systemin and jasmonic acid. Plant Physiol. 1995;108:1741-1745.
151. Brunelle F, Cloutier C, Michaud D. Colorado potato beetles compensate for tomato cathepsin D inhibitor expressed in transgenic potato. Arch insect Biochem Physiol. 2004;55:103-113.
152. Rickauer M, Fournier J, Esquerre-Tugaye MT. Induction of proteinase inhibitors in tobacco cell suspension culture by elicitors of Phytophthora parasitia var. nicotianae. Plant Physiol. 1989;90:1065-1070.
153. Galesa K, pain R, Jongsma MA, Turk V, Lenarcic B. Structural characterization of thyreoglobulin type-1 domains of equistatin. FEBS Lett. 2003;539:120-124.
154. Lenarcic B, Turk V. Tyreoglobulin type-1 domains in equistatin inhibit both papain-like cystein proteinases and cathepsin D. J Biol Chem. 1999;274:563-566.
155. Martzen MR, McMullen BA, Smith NE, Fujikawa K, Peansky RJ. Primary structure of the major pepsin inhibitor from the internal parasitic nematode Ascaris suum. Biochemistry. 1990;29:7366-7372.
156. Ng KKS, Petersen MM, Charney MM, Garen C, Zalatoris JJ, Rao-Naik C, Dunn BM, Martzen MR, Peansky RJ, James MNG. Structural Basis for the inhibition of porcine pepsin by Ascaris pepsin inhibitor-3. Nat Struct Biol. 2000;7:653-657.
157. Valler MJ, Kay J, Aoyagi T, Dunn BM. The interaction of aspartic proteinases with naturally-occurring inhibitors from actinomycetes and Ascaris lumbricoides. J Enzyme Inhib. 1985;1:77-82.
158. Wiederanders B, Kirschke H. The processing a cathepsin L precursor in vitro. Arch Biochem Biophys. 1989;272:516-521.
159. Kageyama T. Molecular cloning, expression and characterization of an Ascaris inhibitor for pepsin and cathepsin E. Eur J Biochem. 1998;253:804-809.
160. Roberts RC, Hall PK. Specificity of proteinases for the "bait" region of α1-macroglobulin. Ann NY Acad Sci. 1983;421:61-68.
161. Travis J, Salvesen GS. Human plasma proteinase inhibitors. Ann Rev Biochem. 1983;52:655-709.
162. Sottrup-Jensen L, Londlad PB, Stepnik TM, Petersen TE, Magnuson S, Jornvall H. Primary structure of the 'bait'rgion for proteinases in α2-macroglobulin. FEBS Lett. 1981;127:167-173.
163. Bodmer JL, Schnebli HP. Plasma proteinase inhibitors. Schweiz Med Wschr. 1984;114:1359-1363.
164. Lah T, Vihar M, Turk V. Interaction of cathepsin D and pepsin with α2-macroglobulin. In: Aspartic proteinases and their inhibitors. Kostka V. Walter de Gruyter Berlin. 1985:485-490.
165. Sttrup-Jensen L. α-macroglobulins: structure, shape, and mechanism of proteinase complex formation. J Biol Chem. 1989; 264:11539-11542.
166. Thomas DJ, Richards AD, Kay J. Inhibition of aspartic proteinases by α2-macroglobulin. Biochem J. 1989;259:905-907.
167. Gaspar A, Skosey JL, Sequeira W, Teodorescu M. Detection of α2-macroglobulin-associated proteases in the plasma of patients with rheumatoid arthritis. Clin Chem. 1984;30:1517-1522.
168. Gonias SL, Pizzo SV. Conformation and protease binding activity of binary and ternary human α2-macroglobulin-protease complex. J Biol Chem. 1983;258:14682-14692.
169. Barrett AJ, Starkey PM. The interaction of α2-macroglobulin with proteinases. Characteristics and specificity of the reaction, and hypothesis concerning its molecular mechanism. Biochem J. 1973;133:709-724.
170. Blatrix C, Amouch P. Drouet J, Steinbuch M. Study on the plasmatic elimination of the α2-macroglobulin proteinase complexes. Path Biol. 1973;21:11-14.
171. Witt I, Tritschler W, Bablok W. α2-macroglobulin: reference values in serum and plasma with a chromogenic substrate (chromozym® TRX). J Clin Chem Clin Biochem. 1981;19:877-878.
172. Kaplan J, Nielsen ML. Analysis of macrophage surface receptors 1. Binding of α2-macroglobulin-protease complex to rabbit alveolar macrophages. J Biol Chem. 1979;254:7323-7328.
173. Swenson RP, Howard JB. Characterization of alkylamine-sensitive site in α2-macroglobulin. Proc Natl Acad Sci USA. 1979; 7614:4313-4316.
174. Avila JL, Convit J. Inhibition of leucocytic lysosomal enzymes by glicosaminoglycans in vitro. Biochem J. 1975;152:57-64.
175. Weston PD, Poole AR. Antibodies to enzymes and their uses, with specific reference to cathepsin D and other lysosomal enzymes. In: Lysosomes in biology and pathology. Dingle JT (ed). North Holland Elsevier Amsterdam. 1973;3:425-464.
176. Dingle JT, Barrett AJ, Weston PD. Cathepsin D. Characteristics of immunoinhibition and the confirmation of a role in cartilage breakdown. Biochem J. 1971;123:1-13.
177. Kopitar-Jerala N, Puizdar V, Berbic S, Zavasnik-Bergant T, Turk V. A cathepsin D specific monoclonal antibody. Immunol Lett. 2001;77:125-126.
178. Weston PD. A specific antiserum to lylosomal cathepsin D. Immunology. 1969;17:421-428.
179. Dingle JT, Poolo R, Lazarus GS, Barrett AJ. Immunoinhibition of intracellular protein digestion in macrophages. J Exp Med. 1973;137:1124-1141.
180. Tulkens P. Trouet A, Van Hoof F. Immunological inhibition of lysosome function. Nature. 1970;228:1282-1285.
181. Hoffmann RHJ, Ristow J, Veser J, Frank W. properties of two growth stimulating proteins isolated from fetal calf serum. Exp Cell Res. 1973;80:275-280.
182. Yonezawa H, Uchikoba T, Kaneda M. Determination of pepstatin-sensitive carboxyl proteases by using pepstatinyldan-syldiaminopropane (dansyl-pepstatin) as an active site titrant. J Biochem. 1997;122:294-299.
183. Afting EG, Becker ML. Two-step affinity-chromatgraphic purification of cathepsin D from myometrium with high yield. Biochem J. 1981;197:519-522.
184. Gubensek F, Barstow I, Kregar I, Turk V. Rapid isolation of cathepsin D by affinity chromatography on the immobilized synthetic inhibitor. FEBS Lett. 1976;71:42-44.
185. Huang JS, Huang SS, Tang J. Cathepsin D isozymes from porcine spleens. Large scale purification and polypeptide chain arrangements. J Biol Chem. 1979;254:11405-11417.
186. Kregar I, Urh I, Umezawa H, Turk V. Purification of cathepsin D by affinity chromatography on pepstatin-Sepharose resin. Croat Chim Acta. 1977;49:587-592.
187. Conner GE. Isolation of procathepsin D from mature cathepsin D by pepstatin affinity chromatography. Autocatalytic proteolysis of the zymogen from of the enzyme. Biochem J. 1989;263:601-604.
188. Stewart AJ, Piggott NH, May FEB, Westley BR. Mitogenic activity of procathepsin D purified for conditioned medium of breast cancer cells by affinity chromatography on pepstatinyl agarose. Int J Cancer 1994;57:715-718.
189. Strukelj B, Pungercar J, Mesko P, Barlic-Maganja D, Gubensek F, Kregar I, Turk V. Characterisation of aspartic proteinase inhibitors from potato at the gene, cDNA and protein levels. Biol Chem Hoppe Seyler. 1992;373:477-482.
190. Wittlin S, Rösel J, Stover DR. One-step purification of cathepsin D by affinity chromatography using immobilized propeptide sequences. Eur J Biochem. 1998;252:530-536.
191. Huisman W, Lanting L, Doddema HJ, Bouma JMW, Gruber M. Role of individual cathepsins in lysosomal protein digestion as tested by specific inhibitors. Biochim Bioplys Acta. 1974;370:297-307.
192. Kominami E, Ueno T, Muno D, Katunuma N. The selective role of cathepsin B and D in the lysosomal degradation of endogenous and exogenous proteins. FEBS Lett. 1991;287:189-192.
193. Weston PD, Barrett AJ, Dingle JT. Specific inhibition of cartilage breakdown. Nature. 1969;222:285-286.
194. Yamato S, Hirabayashi Y, Sigihara H. an improved procedure for the histochemical demonstration of cathepsin D by the mercury-labeled pepstatin method. Stain Technol. 1984;59:113-120.
195. Yamamoto K, Kamata O, Katsuda N, Kato K. Immunochemical difference between cathepsin D and cathepsin E-like enzyme from rat spleen. J
196. Greenbaum LM. Sutherland JHR. Host cathepsin D response to tumor in the normal and pepstatin-treated mouse. Cancer Res. 1983;43:2584-2587.
197. Iodice AA, Leong V, Weinstock JM. The inhibition by pepstatin of cathepsin D and autolysis of dystrophic muscle. Arch Biochem Biophys. 1966;117:477-486.
198. Lin TY, Williams HR. Inhibition of the local hemorrhagic Shwartzman reaction by an acid proteinase inhibitor, pepstatin. Experientia. 1975;31:209-212.
199. Takashima T, Kawada N, Maeda N, Okuyama H, Uyama N, Seki S, Arakawa T. Pepstatin A attenuates the inhibitory effect of N-acetyl-L-cysteina on proliferation of hepatic myofibroblast (stellate cells). Eur J Pharmacol. 2002;451:265-270.
200. Tumminello FM, Bernacki RJ, Gebbia N, Leto G. Pepstatins: aspartic proteinase inhibitors having potential therapeutic applications. Med Res Rev. 1993;13:199-208.
201. Umezawa H, Aoyagi T. Activities of proteinase inhibitors of micro bal origin. In: Proteinases in mammalian cell and tissues. Barret AJ (ed). North-Holland Publ Comp Amsterdam. 1977:637-662.
202. Jones RCW, Wangensteen SI. Protective effect of cathepsin D antiserum on hemorrhagic shock. Surg Forum. 1975;26:29-31.
203. Salvesen G, Nagase H. Inhibition of proteolytic enzymes. In: Proteolytic enzymes a practical approach. Beynon RJ, Bond JS (eds). IRL Press Oxford. 1994:83-104.
204. Cheng Y, Prusoff WH. Relationship between the inhibition constant (Ki) and the concentration of inhibitor whid causes 50 percent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol. 1973;22:3099-3108.
205. Knight CG. Principles of the design and use of synthetic substrates and inhibitors for tissue proteinases. In: Proteinases in mammalian cells and tissues. Barrett AJ. North-Holland Amsterdam. 1977:583-636.
206. Umezawa H. Structure and activities of protease inhibitors of microbial origin. Meth Enzymol. 1976;45:678-695.
207. Knight CG. Active site titration of peptidases. Meth Enzymol. 1995;248:85-101.
208. Barrett AJ. α2-macroglobulin. Meth Enzymol. 1981;80:737-754.
209. Cassiman JJ, Van Leuven F, Van der Schueren B, Van den Borghe H. Immunohistochemical localization of human alpha2-macroglobulin in connective tissue. Cell Tissue Res. 1980;213:301-310.
210. Sznajd J, Naskalski J. The assessment of activity of inactivated enzyme during catalytical process. Diagn Lab. 1978;14:127-133.
211. Chi CW, Lo SS, Tan FL, Zhang YS, Chu HM. Studies on the mung bean trypsin inhibitor. In: Proteins in biology and medicine. Bradshaw RA, Hill RL, Tang J (eds). Acad Press NY. 1982:341-362.
212. Reid WA, Valler MJ, Kay J. Immunolocalisation of cathepsin D in normal and neoplastic human tissues. J Clin Pathol. 1986;39:1323-1330.
213. Rochefort H, Liaudet E, Garcia M. Alternations and role of human cathepsin D in cancer metastasis. Enzyme Protein. 1996;49:106-116.
214. Matthews ITW, Decker RS, Knight CG. The localization of cathepsin D with a biotin-labeled pepstatin. FEBS Lett. 1981;134:253-255.
215. Matthews ITW, Decker RS, Knight CG. Bimane-labeled pepstatin, a fluorescent probe for the subcellular location of cathepsin D. Biochem J. 1981;199:611-6l7.
216. Alteri E, Bold G, Cozensr. CGP 53437, an orally bioavailable inhibitor of human immunodeficioncy virus type 1 protease with potent antiviral activity. Antimicrob Agents Chemother. 1993;37:2087-2092.
217. Le VD, Mak CC, Lin YC, Elder JH, Wong CH. Structure-activity studies of FIV and HIV protease inhibitors containing allophenylnorstatine. Bioorg Med Chem. 2001;9:1185-1195.
218. Leung D, Abbenate G, Fairlie DP. Protease inhibitors: current ststus and future prospects. J Med Chem. 2000;43:305-341.
219. Ogden RC, Flexner CW. Protease inhibitors in AIDS therapy. Marcel Dekker NY 2001.
220. Patick AK, Potts KE. Protease inhibitors as antiviral agents. Clin Microbiol Rev. 1998;11:614-627.
221. Von der Helm K, Gurtler L, Eberle J, Deinhardt F. Inhibition of HIV replication in cell culture by the specific aspartic protease inhibitor pepstatin A. FEBS Lett. 1989;247:349-352.
222. Wlodawer A, Erickson JW. Structure based inhibitors of HJV-1 protease. Ann Rev Biochem. 1993;62:543-585.
223. Januszewicz W, Januszewicz A, Prejbisz A. Renin inhibitors (Inhibitory reniny). Nefrologia Nadciśnienie Tetnicze. 2006;6:9-14.
224. Jones DM, Sueiras-Diaz J, Szelke M, Leckie BJ, Beattie SR, Morton J, Neidle S, Kuroda R. New rennin inhibitors containing novel analogues of statine. J Pept Res. 1997;50:109-121.
225. Rich DH. Inhibitors of aspartic proteinases. In: Proteinase inhibitors. Barrett A.J, Salvesen G. Elsevier Amsterdam. 1986:179-217.
226. Rosenson RS, Tangney CC. Antiatherothrombotic properties of statins. Implication for cardiovascular event reduction. JAMA. 1998;279:1643-1650.